Recent Updates
Recently added Catalysts
IMMP

Immutep Announces Publication of Abstracts for ASCO 2023 Annual Meeting

Key Takeaway: Immutep Announces Publication of Abstracts for ASCO 2023 Annual Meeting
Price reaction · baseline $2.45 (2023-05-24 close) · hit after-hours · 4 other IMMP headline(s) in the window, move may be shared
day 0 close
-6.1%
day 1
-13.1%
day 3 · peak
-15.5%

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+76%
120-day peak, hindsight
Typical move
5.4%
average across 13 past catalysts
Lead asset
eftilagimod alfa
Phase 3 · Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

Full Press Release Details

Immutep Announces Publication of Abstracts for ASCO 2023 Annual Meeting.
Last updated: May 25, 2023